The leading resource for comprehensive insight and
intelligence on the global psychedelics industry.
Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic healthcare industry.
A data and insights platform for the psychedelic healthcare industry.
The Psychedelics Newsletter tracks key players, innovations and milestones to identify emerging opportunities.
With over 25,000 subscribers, the industry's best read newsletter empowers investors to make informed decisions.
Complimentary subscription: https://bit.ly/3baIGDy
‘Demand for NHS services has skyrocketed over the last two years with the pandemic taking a significant toll on the nation’s wellbeing.’
@ClaireCNWL on @NHSuk expanding children’s mental health services 40%, as 22,000 roles remain unfilled: https://bit.ly/3vR9cws
25% of health practitioners believe psychedelic-assisted therapy should be available on @NHSuk.
The Psychedelics as Medicine Report contains 200+ pages of industry intelligence, so investors can make informed decisions.
Complimentary download: https://psych.global/report
'Every step forward for psychedelics anywhere in the world helps every other jurisdiction that wants to legalise.'
@SSinghal, a supporter of @UHNfoundation which partners with @MAPS, spoke with @Business on the regulation of psilocybin in Canada: https://bloom.bg/3BPK1Os
Kernel Flow provides quantifiable neuroimaging data, empowering researchers to measure the efficacy of psychedelic medicines in real-time.
@KernelCo's CTO, Ryan Field, discussed how the headset accelerates innovation at the sold out PSYCH Symposium: https://youtu.be/64tRd52lFaM $CYBN
Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic science and healthcare industry. Straight to your inbox once a week.
Gain unparalleled market intelligence and insights from thought-leaders and industry experts, identifying lucrative opportunities for investors, operators and regulators.